about
Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesRationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.Novel therapeutic strategies targeting vascular endothelium in essential hypertension.Oxidative stress and early atherosclerosis: novel antioxidant treatment.Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.Adrenergic signaling in heart failure and cardiovascular aging.Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.Comparison of Carvedilol and Metoprolol for Preventing Contrast-Induced Nephropathy after Coronary Angiography.Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults.Nebivolol Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.The effect of nebivolol on internal mammary artery blood flow during coronary artery bypass graft surgery.Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling
P2860
Q28073279-71F46CC6-62EC-4726-9E1A-081367449A5BQ30491698-8092CC49-9BC0-4620-AC12-42ACC601FB5AQ36652837-0919D1B0-FE3D-4AD1-AD14-EB3CC29C63EDQ37798006-E0B0C584-54A3-42E2-B9D0-06125538B11AQ38269619-89B25295-FE32-42D5-8522-DFF03A498E11Q38701409-DF089A0E-FE01-4CEF-888C-FFE216A3CC6AQ38803622-F2807C19-FF51-4449-8976-C65F6A868E40Q39157832-8142DEF2-8199-488C-A7DF-B8CE099CD921Q41889657-8E1344F2-1A11-49BD-BDAC-F80049A67A22Q44375078-8F649F03-DCD1-4CF2-BD75-DD04B3BE608CQ44990862-A4E15DF7-F286-4E95-B858-191D1327E96BQ46969982-4E0A81F6-CD62-40F9-98CF-52657127C2FBQ46989441-9E6CA282-D4B8-424B-8899-150EED0DEC1CQ53721454-BED5CD2F-A68E-48CF-B467-5D12F5836660Q57168113-47B9F689-E11E-4753-8DE6-2E4E2D90E8FB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nitric oxide mechanisms of nebivolol.
@en
Nitric oxide mechanisms of nebivolol.
@nl
type
label
Nitric oxide mechanisms of nebivolol.
@en
Nitric oxide mechanisms of nebivolol.
@nl
prefLabel
Nitric oxide mechanisms of nebivolol.
@en
Nitric oxide mechanisms of nebivolol.
@nl
P2860
P356
P1476
Nitric oxide mechanisms of nebivolol
@en
P2093
Angelo Maffei
Giuseppe Lembo
P2860
P304
P356
10.1177/1753944709104496
P577
2009-05-14T00:00:00Z